XML 16 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jul. 30, 2016
Aug. 01, 2015
Cash flows from operating activities:    
Net loss $ (76,554) $ (73,637)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 48,193 46,226
Amortization of lease-related interests 2,015 2,162
Impairment charges 178 222
Share-based compensation expense 1,516 1,598
Loss (gain) on sale of property, fixtures and equipment 22 (1,490)
Reclassifications of accumulated other comprehensive loss 2,927 3,183
Loss on extinguishment of debt   4,862
Amortization of deferred financing costs 1,704 1,488
Deferred income tax benefit (288) (397)
Changes in operating assets and liabilities:    
Decrease (increase) in merchandise inventories 17,888 (3,132)
Decrease in prepaid expenses and other current assets 22,358 12,120
Decrease in other long-term assets 632 895
Increase in accounts payable 49,514 45,570
Decrease in accrued payroll and benefits and accrued expenses (6,495) (18,242)
Decrease in other long-term liabilities (41) (10,464)
Net cash provided by operating activities 63,569 10,964
Cash flows from investing activities:    
Capital expenditures (25,749) (47,350)
Proceeds from insurance claim   1,510
Proceeds from sale of property, fixtures and equipment 7 84,066
Net cash (used in) provided by investing activities (25,742) 38,226
Cash flows from financing activities:    
Payments on long-term debt and capital lease obligations (303,258) (392,183)
Proceeds from issuance of long-term debt 263,669 370,390
Cash dividends paid   (2,004)
Restricted shares forfeited in lieu of payroll taxes (120) (399)
Proceeds from stock options exercised   454
Deferred financing costs paid (495)  
Increase (decrease) in book overdraft balances 2,545 (13,266)
Net cash used in financing activities (37,659) (37,008)
Net increase in cash and cash equivalents 168 12,182
Cash and cash equivalents at beginning of period 6,879 8,753
Cash and cash equivalents at end of period $ 7,047 $ 20,935